RNF213 and Moyamoya disease: Since dysfunctional mitochondria were recently reported to release immune-stimulatory dsRNA into the cytosol, RNA-dependent inflammation initiated by mitochondrial dysfunction or infections may increase the penetrance of patient mutations in RNF213. SAMHD1 loss of function mutations is known to cause inflammatory vasculopathy including moyamoya angiopathy.